Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1068-1072

  Brun Pascaud, Monique ^a   Rajagopalan Levasseur, Premavathy ^a   Chau, Françoise ^a   Bertrand, Guylène ^a   Garry, Louis ^a   Derouin, Francis ^b   Girard, Pierre Marie ^c  

^a BICHAT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL ROTHSCHILD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLARITHROMYCIN; CORTICOSTEROID; DAPSONE; RIFABUTIN; ROXITHROMYCIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; DISEASE ACTIVITY; DRUG ACTIVITY; DRUG EFFICACY; IMMUNE DEFICIENCY; INTRAGASTRIC DRUG ADMINISTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RAT; SUPERINFECTION; SURVIVAL RATE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0031970828     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1068     Document Type: Article

References (41)

1. Adler, J., M. Mitten, N. Shipkowitz, L. Hernandez, Y. Hui, K. Marsh, and J. Clement. 1994. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole. J. Antimicrob. Chemother. 33:253-263.
2. Araujo, F. G., J. Huskinson, and J. S. Remington. 1991. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Taxoplasma gondii. Antimicrob. Agents Chemother. 35:293-299.
3. Araujo, F. G., T. Slifer, and J. S. Remington. 1994. Rifabutin is active in murine models of toxoplasmosis. Antimicrob. Agents Chemother. 38:570-575.
4. Bartlett, M. S., J. A. Fishman, S. F. Queener, M. M. Durkin, M. A. Jay, and J. W. Smith. 1988. New rat model of Pneumocystis carinii infection. J. Clin. Microbiol. 26:1100-1102.
5. Bermudez, L. E., P. Kolonoski, and L. S. Young. 1996. Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice. Antimicrob. Agents Chemother. 40:1033-1035.
6. Brown, S., F. Edwards, E. Bernar, W. Tong, and D. Armstrong. 1993. Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. Antimicrob. Agents Chemother. 37:398-402.
7. Brown, S. T., F. F. Edwards, E. M. Bernard, Y. Niki, and D. Armstrong. 1991. Progressive disseminated infection with Mycobacterium avium complex after intravenous and oral challenge in cyclosporine-treated rats. J. Infect. Dis. 164:922-927.
8. Brun-Pascaud, M. G. Bertrand, F. Chau, P. Rajagopalan-Levasseur, L. Garry, F. Derouin, and P. M. Girard. 1996. Rat model of concurrent Pneumocystis carinii (Pc), Taxoplasma gondii (Tg) and Mycobacterium avium complex (MAC) infections for assessment of multiple prophylaxis, abstr. 196, p. 203. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Brun-Pascaud, M., F. Chau, F. Derouin, and P. M. Girard. 1996. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model. J. Eukaryot. Microbiol. 43:14S-15S.
10. Brun-Pascaud, M., F. Chau, F. Derouin, and P. M. Girard. 1998. Experimental evaluation of roxithromycin combined with dapsone or sulfamethoxazole on pneumocystosis and toxoplasmosis dual infections in rat model. J. Antimicrob. Chemother. 41(Suppl. B):57-62.
11. Brun-Pascaud, M., F. Chau, L. Garry, D. Jacobus, F. Derouin, and P. M. Girard. 1996. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model. Antimicrob. Agents Chemother. 40:2067-2070.
12. Brun-Pascaud, M., F. Chau, A. M. Simonpoli, P. M. Girard, F. Derouin, and J. J. Pocidalo. 1994. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis. J. Infect. Dis. 170:653-658.
13. Carr, A., B. Tindall, B. J. Brew, D. J. Marriott, J. L. Harkness, R. Penny, and D. A. Cooper. 1992. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmosis encephalitis in patients with AIDS. Ann. Intern. Med. 117: 106-111.
14. Cohen, Y., C. Perronne, T. Lazard, C. Truffot-Pernot, J. Grosset, J. L. Vildé, and J. J. Pocidalo. 1995. Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. Antimicrob. Agents Chemother. 39:735-738.
15. Comley, J. C. W., and A. M. Sterling. 1995. Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii in SCID mice. Antimicrob. Agents Chemother. 39:806-811.
16. Derouin, F., C. Piketty, C. Chastang, F. Chau, B. Rouveix, and J. J. Pocidalo. 1991. Antitoxoplasma effects of dapsone alone and combined with pyrimethamine. Antimicrob. Agents Chemother. 35:252-255.
17. Fraser, I., I. Macintosh, and E. G. Wilkins. 1994. Prophylactic effect of co-trimoxazole for Mycobacterium avium complex infection: a previously unreported benefit. Clin. Infect. Dis. 19:211.
18. Frenkel, J. K., J. T. Good, and J. A. Schultz. 1966. Latent pneumocystis infection in rats, relapse and chemotherapy. Lab. Invest. 15:1559-1577.
19. Gangadharam, P. R. 1995. Beige mouse model for Mycobacterium avium complex disease. Antimicrob. Agents Chemother. 39:1647-1654.
20. Gangadharam, P. R. J., D. R. Ashtekar, D. L. Flasher, and N. Düzgünes. 1995. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob. Agents Chemother. 39:725-730.
21. Girard, P. M., R. Landman, C. Gaudebout, et al. 1993. A controlled trial of dapsone-pyrimethamine versus pentamidinc aerosols for primary prophylaxis of Pneumocystis carinii pneumonia and opportunistic toxoplasmosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 328:1514-1520.
22. Grosset, J., C. Truffot, J. Fermanian, and H. Lecoeur. 1982. Activité stérilisante des différents antibiotiques dans la tuberculose expérimentale de la souris. Pathol. Biol. 30:444-446.
23. Hoover, D. R., A. J. Saah, A. J. Bacellar, J. Phair, R. Detels, R. Anderson, R. A. Kaslow, for the Multicenter AIDS Cohort Study. 1993. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N. Engl. J. Med. 329:1922-1926.
24. Hughes, W. T. 1989. Animal models for Pneumocystis carinii pneumonia. J. Protozool. 36:41-45.
25. Hughes, W. T., J. T. Killmar, and H. S. Oz. 1994. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in animal model. J. Infect. Dis. 170:906-911.
26. Kaplan, J. E., H. Masur, K. K. Holmes, C. M. Wilfert, R. Sperling, S. A. Baker, C. Braun Trapnell, K. A. Freedberg, D. Cotton, W. G. Powderly, and H. W. Jaffe, and the USPHS/IDSA Prevention of Opportunistic Infections Working Group. 1995. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clin. Infect. Dis. 21:S12-S31.
27. Lazard, T., C. Perronne, J. Grosset, J. L. Vildé, and J. J. Pocidalo. 1993. Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. Antimicrob. Agents Chemother. 37:1690-1692.
28. Masur, H. 1992. Prevention and treatment of Pneumocystis pneumonia. N. Engl. J. Med. 327:1853-1860.
29. Meyer, S. C. C., S. K. Majumder, and M. H. Cynamon. 1995. In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex. Antimicrob. Agents Chemother. 39:1862-1863.
30. Ostroff, S. M., R. A. Spiegel, J. Feinberg, C. A. Benson, and C. R. Horsburgh. 1995. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 21: 72S-76S.
31. Perronne, C., Y. Cohen, C. Truffot-Pernot, J. Grosset, J. L. Vildé, and J. J. Pocidalo. 1992. Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice. Antimicrob. Agents Chemother. 36:2408-2412.
32. Pierce, M., S. Crampton, D. Henry, L. Heifets, A. LaMarca, M. Montecalvo, G. Wormser, H. Jablonowski, J. Jemsek, M. Cynamon, B. Yangco, G. Notario, and C. Craft. 1996. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N. Engl. J. Med. 335: 384-391.
33. Piketty, C., F. Derouin, B. Rouveix, and J. J. Pocidalo. 1990. In vivo assessment of antimicrobial agents against T. gondii. Quantification of parasites in blood, lungs and brain of infected mice. Antimicrob. Agents Chemother. 34: 1467-1472.
34. Rastogi, N., V. Labrousse, and A. Bryskier. 1995. Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages. Antimicrob. Agents Chemother. 39:976-978.
35. Romand, S., C. Della Bruna, R. Farinotti, and F. Derouin. 1996. In vitro and in vivo effect of rifabutin alone or combined with atovaquone against Toxoplasma gondii. Antimicrob. Agents Chemother. 40:2015-2020.
36. Romand, S., M. Pudney, and F. Derouin. 1993. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob. Agents Chemother. 37:2371-2378.
37. Shafran, S., J. Singer, D. Zarowny, P. Phillips, I. Salit, S. Walmsley, I. Fong, J. Gill, A. Rachlis, R. Lalonde, M. Fanning, C. Tsoukas, for the Canadian HIV Trials Network Protocol 010 Study Group. 1996. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofioxacin. N. Engl. J. Med. 335:377-383.
38. Shah, L., M. DeStephano, and M. Cynamon. 1996. Enhanced in vitro activity of WR99210 in combination with dapsone against Mycobacterium avium complex. Antimicrob. Agents Chemother. 40:2644-2645.
39. United States Public Health Task Force on Antipneumocystis Prophylaxis for Patients with Human Immunodeficiency Virus Infection. 1992. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morbid. Mortal. Weekly Rep. 41:1-11.
40. Walzer, P. D., J. Foy, P. Steele, and M. White. 1992. Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. Antimicrob. Agents Chemother. 36:1943-1950.
41. Young, L. S., L. E. Bermudez, M. Wu, and C. B. Inderlied. 1995. Potential role of roxithromycin against the Mycobacterium avium complex. Infection 23:S28-S32.